SE422060B - Analogiforfarande for framstellning av basiskt substituerade pyridinkarboxamider - Google Patents

Analogiforfarande for framstellning av basiskt substituerade pyridinkarboxamider

Info

Publication number
SE422060B
SE422060B SE7610608A SE7610608A SE422060B SE 422060 B SE422060 B SE 422060B SE 7610608 A SE7610608 A SE 7610608A SE 7610608 A SE7610608 A SE 7610608A SE 422060 B SE422060 B SE 422060B
Authority
SE
Sweden
Prior art keywords
substituted pyridine
preparing basic
analogy procedure
pyridine carboxamides
basic substituted
Prior art date
Application number
SE7610608A
Other languages
English (en)
Other versions
SE7610608L (sv
Inventor
J Gosteli
A Storni
A Zust
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH43575A external-priority patent/CH577300A5/xx
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7610608L publication Critical patent/SE7610608L/sv
Publication of SE422060B publication Critical patent/SE422060B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SE7610608A 1975-01-15 1976-09-24 Analogiforfarande for framstellning av basiskt substituerade pyridinkarboxamider SE422060B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH43575A CH577300A5 (sv) 1974-01-18 1975-01-15

Publications (2)

Publication Number Publication Date
SE7610608L SE7610608L (sv) 1977-03-26
SE422060B true SE422060B (sv) 1982-02-15

Family

ID=4186955

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7610608A SE422060B (sv) 1975-01-15 1976-09-24 Analogiforfarande for framstellning av basiskt substituerade pyridinkarboxamider

Country Status (1)

Country Link
SE (1) SE422060B (sv)

Also Published As

Publication number Publication date
SE7610608L (sv) 1977-03-26

Similar Documents

Publication Publication Date Title
SE430335B (sv) Analogiforfarande for framstellning av pyridinyl-pyridinoner
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE403380B (sv) Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner
SE431872B (sv) Analogiforfarande for framstellning av derivat av 4-pyrimidon
SE428684B (sv) Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE428685B (sv) Analogiforfarande for framstellning av cyanosubstituerade (3-lagalkylamino-2-acyl-0-propoxi)pyridiner
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
DK433076A (da) Fremgangsmade til fremstilling af basisk substituerede pyridincarboxamider
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
SE422210B (sv) Analogiforfarande for framstellning av substituerade indoler
SE439159B (sv) Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat
SE415658B (sv) Analogiforfarande for framstellning av linnolinderivat
SE422794B (sv) Forfarande for framstellning av basiskt substituerade naftalenderivat
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE409868B (sv) Forfarande for framstellning av nya triaminoandrostaner
SE7612565L (sv) Forfarande for framstellning av nya rifamycinforeningar
SE425784B (sv) Analogiforfarande for framstellning av eburnameninderivat
SE418858B (sv) Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin